1-3 of 3
Anjelika Gasilina
Close
Sort by
Journal Articles

The Small Molecule IODVA1 Inhibits the Rac Guanine Nucleotide Exchange Factor Vav3 and Overcomes TKI-Resistance in Ph + (BCR-ABL1) B-ALL

Nicolas Nassar, PhD, Shailaja N Hegde, PhD, Anjelika Gasilina, Mark Wunderlich, MS, Gurdat Premnauth, Edward Merino, PhD, Yuan Lin, PhD, Reza Ahmadian, PhD, Yi Zheng, PhD, Benjamin Mizukawa, Lisa Privette Vinnedge, PhD, Jose A Cancelas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4647.
https://doi.org/10.1182/blood-2019-130250
Published: 2019
Journal Articles

Real-Time Genomic Profiling Identifies Novel Mutations and Improved Therapy for Histiocytoses

Lynn Lee, MD, Anjelika Gasilina, Jayeeta Roychoudhury, PhD, Jason Clark, Francis X McCormack, MD, Joseph Gerald Pressey, MD, Robert B. Lorsbach, MD PhD, Siraj M Ali, MD PhD, Mark Bailey, MSc, Philip Stevens, PhD, Jeffrey S Ross, MD, Vincent A. Miller, MD, Nicolas Nassar, PhD, Ashish R Kumar, MBBS, PhD
Journal: Blood
Blood (2016) 128 (22): 2723.
https://doi.org/10.1182/blood.V128.22.2723.2723
Published: 2016
Journal Articles

Upregulation of Vav3 Is Required for Leukemogenesis By BCR-ABL through Polycomb Repression Complex Dependent De-Repression of the Cdkn2a Locus

Megha Desai, PhD, Kyung-Hee Chang, PhD, E. David Muench, BS, Anjelika Gasilina, Ashley Wellendorf, Xose R Bustelo, H. Leighton Grimes, PhD, Nicolas Nassar, PhD, Jose A Cancelas, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3661.
https://doi.org/10.1182/blood.V126.23.3661.3661
Published: 2015